“We take the responsibility we have to our shareholders very seriously and believe this to be the best course of action for our company,” said Medolife CEO Dr. Arthur Mikaelian. “We held a very informative webcast on Tuesday 7/27 where we covered many of the exciting things that are happening with our company, and we highly encourage our followers to take a moment to watch it. We are in the process of building a global biotechnology company and our future could not be brighter. Thank you to the investment community for its continued support and we look forward to sharing further updates with you all soon.”